Revenue

A landmark executive order to reschedule cannabis and create a Medicare CBD program could unleash a $30B market and redefine the economics of the industry.

NDT Pharmaceuticals' subsidiary launches PurrGuard and Dog Gone Odor, leveraging antimicrobial tech to disrupt the multi-billion-dollar pet hygiene industry.

Pembroke's acquisition of the 280-unit Proto tower in Cambridge marks a strategic pivot to residential real estate in its founding city of Boston.

The fast-growing AI security startup Airia has achieved AWS Validated Partner status, a move to address critical governance and safety gaps for enterprises.

Holiday spending pushed credit balances to a new high, but a sharp rise in delinquencies signals a K-shaped economy where many face a financial reckoning.

In a landmark deal, BioMarin acquires Amicus Therapeutics, gaining high-growth drugs and reshaping the landscape for patients with rare genetic disorders.

Loyola Marymount University is expanding its EV charging with ChargePoint's AI platform and maintenance service, creating a reliable network for its community.

A landmark executive order reclassifying cannabis is set to unleash a wave of biopharma innovation, validating science-first firms like Avicanna.

Aduro Clean Technologies raises $20M for a key plant, navigating market jitters to fund its game-changing chemical recycling technology.

The latest VyOS release adds TLS for syslog, AWS GWLB support, and RPKI controls, boosting security and flexibility for modern network infrastructures.

A strategic partnership aims to merge respiratory rentals with innovative hygiene products, promising better compliance and comfort for millions of CPAP users.

A trio of real estate giants will build a massive rental complex in Vieux-Longueuil, a major move to address the South Shore's critical housing shortage.

The powerboat giant expands its share repurchase in a show of financial strength, betting on long-term recovery despite a soft recreational market.

In a high-level diplomatic dinner, Argentina's ambassador showcased President Milei's sweeping reforms, signaling a new chapter for UK investment.

A cancer research firm is betting its future on Zcash, recruiting the crypto's top minds. Is this the start of institutional adoption for privacy coins?

Alvotech and Teva's settlement with Regeneron for an Eylea biosimilar paves the way for a 2026 launch, promising increased competition and lower costs.

Danish water tech firm Aquaporin seeks urgent funding, warning of 77% dilution for shareholders as it races to secure its future and new technology.

Facing a cash crunch, the Danish innovator seeks funds to survive, betting its future on a next-gen biotech solution to global water challenges.

A new settlement positions a cost-effective alternative to the blockbuster eye drug Eylea for a 2026 U.S. launch, signaling intense market disruption.

A new partnership between power module expert SOLUM and charger innovator i-charging aims to supercharge e-mobility with next-gen tech and a human-centric vision.